Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 374.56B | 366.74B | 351.11B | 354.91B | 355.90B | 271.52B |
Gross Profit | 104.57B | 106.45B | 100.30B | 101.80B | 101.98B | 75.71B |
EBITDA | 17.83B | 17.42B | 14.60B | 15.18B | 14.18B | 9.20B |
Net Income | 8.61B | 8.31B | 6.17B | 7.59B | 5.30B | 2.94B |
Balance Sheet | ||||||
Total Assets | 141.43B | 133.25B | 119.39B | 117.18B | 130.81B | 119.86B |
Cash, Cash Equivalents and Short-Term Investments | 37.70B | 12.36B | 13.20B | 14.22B | 19.60B | 15.02B |
Total Debt | 0.00 | 1.64B | 1.87B | 2.03B | 2.17B | 2.92B |
Total Liabilities | 56.95B | 52.65B | 45.62B | 47.76B | 56.53B | 49.19B |
Stockholders Equity | 84.48B | 80.59B | 73.77B | 69.39B | 74.24B | 70.62B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 11.88B | 3.42B | 997.00M | 13.18B | 1.25B |
Operating Cash Flow | 0.00 | 18.23B | 10.50B | 6.36B | 18.85B | 4.63B |
Investing Cash Flow | 0.00 | -6.49B | -7.15B | -5.41B | -5.93B | 2.11B |
Financing Cash Flow | 0.00 | -2.12B | -2.19B | -12.87B | -2.31B | -1.49B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥59.15B | 11.59 | 1.44% | 13.93% | -11.16% | ||
78 Outperform | ¥155.66B | 12.56 | 1.55% | 10.21% | 16.03% | ||
78 Outperform | ¥194.56B | 11.34 | 1.13% | 5.04% | 8.60% | ||
77 Outperform | ¥100.24B | 10.70 | 2.22% | 2.91% | 12.82% | ||
72 Outperform | ¥99.09B | 11.01 | 1.38% | 7.94% | 0.06% | ||
68 Neutral | ¥61.86B | 11.59 | 1.98% | 5.78% | 10.78% | ||
63 Neutral | €16.07B | 12.72 | -4.55% | 4.03% | -1.83% | -144.94% |